Biotech platform for the early diagnosis of viral infections

Our breath analysers identify common respiratory infections from a single exhalation, even before the manifestation of symptoms

respiratory viral infections, a global challenge

deaths annually are caused by acute respiratory infections, a leading cause of death globally: 4.25M
of total actual respiratory infection cases are undiagnosed: > 97%
annual cost of respiratory viral infections in the EU and US: $100B

With the majority of cases remaining undiagnosed and a significant risk of future pandemics, earlier and faster diagnosis is key to reducing the spread of emerging viral infections, enabling timely treatment and mitigating their burden.

we turn invisible into visible

by identifying and measuring multiple viral strains in the exhaled air in near real time

The patient feels unwell or has had recent contact with an infected person

The doctor or pharmacist offers a VAir rapid respiratory test

From the first breath, the device identifies the pathogen and the stage of the infection

Health professional receives the results in less than 3 minutes with a prediction of the stage of the infection

For the next test, the sterile tip is changed. Pathogens are inactivated inside the device by irradiation

Three layers of innovation

One complete diagnostic solution

1. VAir Device

Breath analyser (IVD MD) for non-invasive detection of multiple respiratory viruses, such as SARS-CoV-2, RSV and influenza strains, in exhaled breath at the point of care

2. VAir Intelligence

A powerful combination of specific antibody recognition and a highly sensitive measurement system. Provides unparalleled accuracy in identifying viral pathogens and detecting infections in their earliest stages.

3. VAir App

Dashboard showing historical data and real-time results. Diagnosis and monitoring of patient responses to previous infections for more informed and personalised care decisions.

Why choose VAir?

By combining the high accuracy and reliability of molecular diagnostics with the portability and rapid analysis capabilities of point-of-care solutions, we are making diagnostics faster, more accessible and scalable, significantly reducing the burden on healthcare systems.

	Molecular diagnostics (RT-PCR)	Rapid diagnostic tests	VAir
Analysis time	4–24 h	5–60 min	< 3 min
Sensitivity	97–99%	50–80%	> 90%
Automatic diagnostics	–	Depends on the type of test	✓
Minimal waste production	–	–	✓
Cost per test (for > 1000 tests)	$40–$72	$3–$31	< $5
Multiplexity	Depends on the type of test	Depends on the type of test	✓
Non-invasiveness	–	Depends on the type of test	✓

Interested to be among our first users?

Join waitlist

They support us